Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-07 4:41 pm Purchase | 2021-12-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | BlackRock Inc. BLK | 3,689,894 7.000% | 1,369,488 (+59.02%) | Filing History |
| 2022-02-04 09:24 am Sale | 2021-12-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | WELLINGTON MANAGEMENT GROUP LLP | 1,598,766 3.040% | -1,016,677 (-38.87%) | Filing History |
| 2021-12-23 5:28 pm Purchase | 2021-12-20 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Frazier Life Sciences Public Fund, L.P. | 2,772,062 5.600% | 2,772,062 (New Position) | Filing History |
| 2021-05-10 4:05 pm Purchase | 2021-04-28 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,700,000 5.600% | 1,450,000 (+116.00%) | Filing History |
| 2021-05-03 3:15 pm Purchase | 2021-04-21 | 13D | SYNDAX PHARMACEUTICALS INC SNDX | Access Industries Holdings LLC | 2,682,387 5.560% | 544,187 (+25.45%) | Filing History |